Stock SPRY ARS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
8.7 USD +1.16% Intraday chart for ARS Pharmaceuticals, Inc. +2.35% +58.76%
Apr. 18 ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing MT
Apr. 18 ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing MT

Business Summary

ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.

Number of employees: 25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 96,894,394 69,689,286 ( 71.92 %) 0 71.92 %

Shareholders

NameEquities%Valuation
Deerfield Management Co. LP (Private Equity)
11.48 %
11,077,927 11.48 % 113 M $
RA Capital Management LP
11.25 %
10,860,977 11.25 % 111 M $
Pratik Shah
10.52 %
10,156,204 10.52 % 104 M $
RA Capital Management LP
9.803 %
9,459,678 9.803 % 97 M $
Richard Lowenthal
9.801 %
9,457,753 9.801 % 97 M $
OrbiMed Advisors Private Equity
9.576 %
9,240,887 9.576 % 94 M $
Sarina Tanimoto
5.239 %
5,055,294 5.239 % 52 M $
Robert Bell
4.366 %
4,213,504 4.366 % 43 M $
Fiduciary Trust International LLC
4.247 %
4,098,497 4.247 % 42 M $
SR One Capital Management LP
4.158 %
4,012,903 4.158 % 41 M $

Company contact information

ARS Pharmaceuticals, Inc.

11682 El Camino Real Suite 120

92130, San Diego

+

http://www.ars-pharma.com
address ARS Pharmaceuticals, Inc.(SPRY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Ratings for ARS Pharmaceuticals, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.6 USD
Average target price
19 USD
Spread / Average Target
+120.93%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ARS PHARMACEUTICALS, INC. Stock ARS Pharmaceuticals, Inc.
+58.76% 833M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.86B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.74B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. Company ARS Pharmaceuticals, Inc.